Studies of Blood Glucose and the Microbiome in Tumors and Cysts of the Pancreas

ConditionsPancreatic Neoplasms Pancreatic Cysts Hyperglycemia Prediabetes

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorUmeå University

About this trial

This prospective, single-center observational study investigates whether continuous glucose monitoring (CGM, 14 days) and gut microbiota composition (from a fecal sample) reveal patterns specific to pancreatic cancer, aiming to contribute to earlier detection and better assessment of disease severity. Adult patients under investigation, follow-up, or treatment for benign or malignant pancreatic/periampullary conditions are invited to participate in either or both parts of the study.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults (≥18 years of age).

Undergoing clinical investigation, follow-up, or treatment for a pancreatic or periampullary condition (malignant or benign/premalignant, including cystic lesions and pancreatitis).

Willing and able to provide written informed consent for participation in at least one component of the study (continuous glucose monitoring and/or fecal sample collection).

Disqualifiers

None

Trial population

The study population consists of consecutive adult patients evaluated or treated for pancreatic or periampullary diseases at the Department of Surgery/Cancer Center, Umeå University Hospital, Sweden.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

100 Participants

are grouped into 2 trial groups

Group A: Patients with pancreatic cancer

Group B: Patients with cysts or other benign pancreatic disease

Trial outcomes

Primary outcomes

Difference in CGM-derived glycemic variability metrics

Time frame

14 days CGM recording period

Difference in gut microbiota composition

Time frame

Single fecal sample

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Umeå University

Lead sponsor

Region Västerbotten

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: